Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Working Capital Changes: 2017-2024

Historic Other Working Capital Changes for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to $19.6 million.

  • Kiniksa Pharmaceuticals International's Other Working Capital Changes fell 92.75% to $507,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year increase of 105.41%. This contributed to the annual value of $19.6 million for FY2024, which is 176.64% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Other Working Capital Changes stood at $19.6 million for FY2024, which was up 176.64% from $7.1 million recorded in FY2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Other Working Capital Changes peaked at $19.6 million during FY2024, and registered a low of -$2.9 million during FY2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was $12.0 million (2022), whereas its average is $12.9 million.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Other Working Capital Changes slumped by 73.10% in 2021 and then soared by 508.02% in 2022.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Other Working Capital Changes (Yearly) stood at -$1.7 million in 2020, then plummeted by 73.10% to -$2.9 million in 2021, then soared by 508.02% to $12.0 million in 2022, then tumbled by 41.11% to $7.1 million in 2023, then spiked by 176.64% to $19.6 million in 2024.